These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6291813

  • 1. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A, Luetscher JA, Weinberger MH.
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [Abstract] [Full Text] [Related]

  • 2. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC, Weinberger MH, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S, Nugent CA.
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [Abstract] [Full Text] [Related]

  • 3. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB.
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [Abstract] [Full Text] [Related]

  • 4. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
    Shigemasa C, Kouchi T, Yoshida A, Mashiba H.
    J Med; 1991 Apr; 22(3):187-93. PubMed ID: 1663149
    [Abstract] [Full Text] [Related]

  • 5. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
    Biglieri EG, Schambelan M.
    J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
    [Abstract] [Full Text] [Related]

  • 6. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF, Dale SL, Kahn PC, Melby JC.
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [Abstract] [Full Text] [Related]

  • 7. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H, Ichikawa S, Sakamaki T, Nakamura T, Ono Z, Takayama Y, Murata K.
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [Abstract] [Full Text] [Related]

  • 8. Triamterene-thiazide combination: alternative therapy for primary aldosteronism.
    Ganguly A, Weinberger MH.
    Clin Pharmacol Ther; 1981 Aug; 30(2):246-50. PubMed ID: 7018790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ.
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [Abstract] [Full Text] [Related]

  • 11. Primary aldosteronism due to unilateral adrenal hyperplasia.
    Ganguly A, Zager PG, Luetscher JA.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1190-4. PubMed ID: 6252233
    [Abstract] [Full Text] [Related]

  • 12. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
    Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG.
    J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia.
    Mantero F, Gion M, Armanini D, Opocher G.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():329s-332s. PubMed ID: 192515
    [Abstract] [Full Text] [Related]

  • 14. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
    Horton R.
    Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
    [No Abstract] [Full Text] [Related]

  • 15. ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism.
    Wenting GJ, Man in't Veld AJ, Derkx FH, Brummelen PV, Schalekamp MA.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):326-35. PubMed ID: 220277
    [No Abstract] [Full Text] [Related]

  • 16. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R, Yamazaki T, Ito Y, Koshida H, Morise T, Miyamori I, Hashimoto T, Morimoto S.
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment.
    Yagi A, Ichikawa S, Sakamaki T, Ono Z, Sato K, Nakamura T, Sakamoto H, Murata K.
    Eur J Endocrinol; 1994 Sep; 131(3):215-20. PubMed ID: 7921203
    [Abstract] [Full Text] [Related]

  • 18. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H, Vetter W.
    Klin Wochenschr; 1975 Apr 15; 53(8):391-3. PubMed ID: 211313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.